z-logo
open-access-imgOpen Access
Current Trends in the Gene Therapy of Hematologic Disorders
Author(s) -
Dragomira Nikolova
Publication year - 2021
Publication title -
acta medica bulgarica/acta medica bulgarica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.12
H-Index - 5
eISSN - 2719-5384
pISSN - 0324-1750
DOI - 10.2478/amb-2021-0048
Subject(s) - genetic enhancement , medicine , disease , gene , bioinformatics , biology , genetics , pathology
Recent advances in molecular genetics and the invention of new technologies led to an advance in the development of gene therapy. Gene therapy is used to correct defective genes in order to cure a disease or help the body better fight a disease. It works by restoring or modifying cellular functions through the introduction of a functional gene into the target cell. The concept of gene therapy is simple, but introducing it to routine clinical practice is not. The main concerns are related to some safety issues as well as to the problem that maintaining a stable and prolonged expression in target cells may not be easily achieved. In spite of the difficulties, gene therapy remains a hope for many hematological disorders that cannot be effectively treated so far. This article reviews the current status of gene therapy with a focus on hematological disorders. In addition, clinically applied approaches are presented through particular examples of approved gene therapy drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here